Cancer incidence and mortality rates are rapidly increasing worldwide, due to multiple reason such as an aging and growing population, and changes in risk factors associated with cancer. Several forms of cancer can affect each organ system. This is a case report involving a 80 year old female diagnosed initially with aspiration pneumonia and then lost to follow up for several years. She was again diagnosed with pneumonia, however required hospitalization a short while after that time. Further workup yielded a differential of multifocal pneumonia or interstitial lung disease, and later a diagnosis of advanced stage mucinous adenocarcinoma of the lung. This particular cancer has nonspecific clinical and radiological findings and has been known remain localized until its advanced stages. Consequently, it could have been curative with proper follow up after initial presentation.

References

1. Bray F., et al. “Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries”. CA: A Cancer Journal for Clinicians 68.6 (2018): 394-424. 
2. Kirk D Jones. “Whence Lepidic? The History of a Canadian Neologism”. Archives of Pathology and Laboratory Medicine 137.12 (2013): 1822-1824.
3. Travis WD., et al. “The 2015 World Health Organization Classification of Lung Tumors: Impact of Genetic, Clinical and Radiologic Advances Since the 2004 Classification”. Journal of thoracic oncology: official publication of the International Association for the Study of Lung Cancer (2015).
4. Popper HH. “Cons: the confusing mucinous adenocarcinoma classification”. Translational Lung Cancer Research 6.2 (2017): 234-240. 
5. Koo HJ., et al. “Computerized margin and texture analyses for differentiating bacterial pneumonia and invasive mucinous adenocarcinoma presenting as consolidation”. PLoS One 12.5 (2017): e0177379. 
6. Travis WD., et al. “Tumors of the lung. WHO classification of tumors of the lung, pleura, thymus and heart”. Lyon: International Agency for Research on Cancer (2015): 9-151.
7. Moon SW., et al. “Effect of invasive mucinous adenocarcinoma on lung cancer-specific survival after surgical resection: a population-based study”. Journal of Thoracic Disease 10.6 (2018): 3595-3608. 
8. Lee HY., et al. “Prognosis in Resected Invasive Mucinous Adenocarcinomas of the Lung: Related Factors and Comparison with Resected Nonmucinous Adenocarcinomas”. Journal of thoracic oncology: official publication of the International Association for the Study of Lung Cancer (2016). 
9. Warth A., et al. “The novel histologic International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society classification system of lung adenocarcinoma is a stage-independent predictor of survival”. Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology (2019).
10. Lilenbaum RC. Overview of the initial treatment of advanced non-small cell lung cancer (2019).

Citation

Citation: Jay Patolia., et al. “Delayed Diagnosis: Pulmonary Invasive Mucinous Adenocarcinoma Presenting as Interstitial Lung Disease". Acta Scientific Cancer Biology 4.3 (2020): 05-07.

Copyright

Copyright: © 2020 Jay Patolia., et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.